BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Closed|| Long (1Y)
Religare downgrades Natco Pharma to sell
Religare has downgraded Natco Pharma to sell for target price of Rs 655 per share. It says valuations have become expensive following the recent run-up in stock price.